Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2025 12:59 ET | Source: National Civil Rights Museum

National Civil Rights Museum and Unite Memphis Announce Next-Level Partnership

Memphis, TN, March 04, 2025 (GLOBE NEWSWIRE) -- The National Civil Rights Museum and Unite Memphis today announced a new partnership to amplify the message and movement of healing, honor, and hope...
September 23, 2024 15:00 ET | Source: Custom Market Insights

[Latest] Global Metaverse In E-commerce Market Size/Share Worth USD 110.6 Billion by 2033 at a 39.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Metaverse In E-commerce Market Size, Trends and Insights By Platform (Desktop,...
July 18, 2024 10:00 ET | Source: National Comedy Theatre

National Comedy Theatre to celebrate 25 years of bringing laughter to the community

SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- San Diego’s funniest night out is celebrating 25 years of laughs with the community this fall. National Comedy Theatre has entertained audiences of all...
April 24, 2023 07:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema

A single injection of UBX1325 led to a statistically significant and clinically meaningful improvement in Best Corrected Visual Acuity (BCVA) of +6.2 ETDRS letters from baseline at 48 weeks ...
April 23, 2023 18:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology to Host Program Update on BEHOLD, the Phase 2 Clinical Trial of UBX1325 in Patients with Diabetic Macular Edema

SOUTH SAN FRANCISCO, Calif., April 23, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases...
September 19, 2022 08:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology Completes Enrollment in Phase 2 ENVISION Study of UBX1325 in Wet Age-related Macular Degeneration

Enrollment of 51 patients exceeds target by ~10% due to high interest in the study 16-week data anticipated in Q1 2023 and 24-week data anticipated in Q2 2023 SOUTH SAN FRANCISCO, Calif., Sept. 19,...
August 31, 2022 21:00 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Unity, Amazon, Outset Medical, and Missfresh and Encourages Investors to Contact the Firm

NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
August 26, 2022 21:00 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wells Fargo, Unity, Amazon, and Outset Medical and Encourages Investors to Contact the Firm

NEW YORK, Aug. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
August 21, 2022 21:00 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inotiv, Wells Fargo, Unity, and Amazon and Encourages Investors to Contact the Firm

NEW YORK, Aug. 21, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
August 15, 2022 21:00 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yext, Inotiv, Wells Fargo, and Unity Software and Encourages Investors to Contact the Firm

NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...

Next Page keyboard_arrow_right